TaiAx Capital
Overview
TaiAx Capital is a venture capital firm, operating as an international joint venture between Taiwania Capital Management and Axil Capital Group, that focuses on investing in transformative innovations within the life science sector.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Fore Biotherapeutics | Jul 2026 | Series D-2 Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is TaiAx Capital based?
TaiAx Capital is headquartered in Tokyo, Japan.
When was TaiAx Capital founded?
TaiAx Capital was founded in 2024.
How many portfolio companies does TaiAx Capital have?
TaiAx Capital has 1 portfolio company in Caplight's dataset.
What are some companies in TaiAx Capital's portfolio?
Portfolio companies visible on Caplight include Fore Biotherapeutics.
What was TaiAx Capital's most recent investment shown here?
TaiAx Capital's most recent investment in this portfolio sample was in Fore Biotherapeutics in 2026.
What sectors does TaiAx Capital focus on?
TaiAx Capital focuses on Healthcare & Life Sciences.
What company stages does TaiAx Capital focus on?
TaiAx Capital typically invests at the Late stage.
What is TaiAx Capital's AUM?
TaiAx Capital's assets under management are estimated at up to $200.0M.